Immunoradiomatric assay technique was used to measure the level of serum tumor markers CA125 and CEA in 30 healthy women, 24 patients with benign ovarian tumors and 34 patients with malignant ovarian tumors.

Due to delays in procuring the appropriate approvals from the Institutional Review Boards we have not been able to initiate the proposed studies.

Statistically, approximately sixty American women are discovered daily with ovarian cancer. Around forty of those will die every day. This book describes early signs that should never be ignored. If in doubt, shout!